Stay updated on Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was applied to the site, and the previous notice about government funding operating status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:30:40.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide funding-status notice and updated the page revision to v3.4.1; no study content or data were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:24:35.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata labels such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while adjusting older wording like 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data'. These are minor UI/metadata changes that do not affect core study information or user actions; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:16:53.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4, with no observable changes to study content, eligibility criteria, or outcomes. No core study information was modified. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:14:45.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added a Locations section listing Oregon as a study site and removed the HHS Vulnerability Disclosure item.
    Difference
    0.2%
    Check dated 2025-12-23T09:26:54.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The update shows a minor revision from v3.2.0 to v3.3.2; no substantive content or feature changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:45:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.